Kistler-Tiffany Companies’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $55.5K | Hold |
640
| – | – | 0.01% | 479 |
|
|
2023
Q1 | $62.2K | Hold |
640
| – | – | 0.01% | 415 |
|
|
2022
Q4 | $66.2K | Sell |
640
-740
| -54% | -$76.6K | 0.01% | 393 |
|
|
2022
Q3 | $117K | Hold |
1,380
| – | – | 0.03% | 260 |
|
|
2022
Q2 | $114K | Buy |
1,380
+65
| +5% | +$5.37K | 0.02% | 270 |
|
|
2022
Q1 | $101K | Buy |
1,315
+20
| +2% | +$1.54K | 0.02% | 299 |
|
|
2021
Q4 | $114K | Buy |
1,295
+30
| +2% | +$2.64K | 0.02% | 263 |
|
|
2021
Q3 | $98K | Buy |
1,265
+185
| +17% | +$14.3K | 0.02% | 278 |
|
|
2021
Q2 | $90K | Buy |
1,080
+142
| +15% | +$11.8K | 0.02% | 289 |
|
|
2021
Q1 | $71K | Buy |
938
+130
| +16% | +$9.84K | 0.02% | 287 |
|
|
2020
Q4 | $71K | Sell |
808
-320
| -28% | -$28.1K | 0.02% | 262 |
|
|
2020
Q3 | $86K | Sell |
1,128
-510
| -31% | -$38.9K | 0.03% | 228 |
|
|
2020
Q2 | $202K | Sell |
1,638
-882
| -35% | -$109K | 0.07% | 137 |
|
|
2020
Q1 | $213K | Hold |
2,520
| – | – | 0.08% | 135 |
|
|
2019
Q4 | $213K | Hold |
2,520
| – | – | 0.07% | 138 |
|
|
2019
Q3 | $170K | Buy |
2,520
+540
| +27% | +$36.4K | 0.06% | 146 |
|
|
2019
Q2 | $170K | Buy |
1,980
+1,708
| +628% | +$147K | 0.06% | 142 |
|
|
2019
Q1 | $24K | Buy |
+272
| New | +$24K | 0.01% | 325 |
|